Teva Canada Limited (Teva Canada) announced today that Health Canada has approved an expanded indication for PrAJOVY® ...

Use of Botox as diagnostic model for migraine headache has positive predictive value of 89.5%. HealthDay News — Diagnostic targeted Botox injections have high positive predictive value for migraine ...

More than a billion people worldwide struggle to find relief from the unbearable pain of migraine. But research is leading to ...

Please provide your email address to receive an email when new articles are posted on . The study included 58 young persons with migraine flares lasting 24 hours to 3 months. A majority of those given ...

CINCINNATI (WKRC) - A medication previously available only for adults is now on the market for children to help reduce migraines. Recent research focused on children aged six to 17 and examined a ...

It began as an odd observation among plastic surgery patients, and ended up as an FDA approved drug — on Friday, the agency green-lighted the use of Botox, a popular wrinkle-reducing procedure, to ...

Dr. Reddy's Laboratories (NYSE: RDY), announced today that the U.S. Food and Drug Administration (FDA) has approved ZEMBRACE™SymTouch™ (sumatriptan succinate) injection, a drug-device combination ...

“When I got here in Muscatine, we were looking at needs in the community and discovered that there is a real lack of access to neurology and migraine management in the area, so given that I had some ...

(Reuters) - Amgen Inc's push to get patients on its new $575 a month migraine drug before competition emerges in September is facing barriers from insurers. Bracing for a flood of costly prescription ...